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Abstract. 
 
During skeletogenesis, cartilage develops to
either permanent cartilage that persists through life or
transient cartilage that is eventually replaced by bone.
However, the mechanism by which cartilage phenotype
 
is speciﬁed remains unclariﬁed. Core binding factor 
 
a
 
1
(Cbfa1) is an essential transcription factor for osteo-
blast differentiation and bone formation and has the
ability to stimulate chondrocyte maturation in vitro. To
understand the roles of Cbfa1 in chondrocytes during
skeletal development, we generated transgenic mice
that overexpress Cbfa1 or a dominant negative (DN)-
Cbfa1 in chondrocytes under the control of a type II
collagen promoter/enhancer. Both types of transgenic
mice displayed dwarﬁsm and skeletal malformations,
which, however, resulted from opposite cellular pheno-
 
types. Cbfa1 overexpression caused acceleration of endo-
chondral  ossiﬁcation due to precocious chondrocyte
maturation, whereas overexpression of DN-Cbfa1
suppressed maturation and delayed endochondral
 
ossiﬁcation. In addition, 
 
Cbfa1
 
 transgenic mice failed
to form most of their joints and permanent cartilage
entered the endochondral pathway, whereas most chon-
 
drocytes in DN-
 
Cbfa1
 
 transgenic mice retained a marker
for permanent cartilage. These data show that temporally
and spatially regulated expression of Cbfa1 in chondro-
cytes is required for skeletogenesis, including formation of
joints, permanent cartilages, and endochondral bones.
Key words: chondrocyte • Cbfa1 • transgenic mice •
endochondral ossiﬁcation • permanent cartilage
 
Introduction
 
Vertebrate skeletons are constructed through the formation
of bone structures at specific times and sites, a process that
 
is achieved by intramembranous or endochondral ossifi-
cation. Intramembranous bones derive from the direct
differentiation of mesenchymal cells into osteoblasts,
whereas endochondral bones first appear as cartilaginous
structures that are then replaced with bone (Gilbert,
1997). Most of the cartilage has transient phenotype and
the chondrocytes proliferate, then enlarge into hyper-
trophic cells, and are finally replaced by osteoblasts dur-
ing endochondral ossification. However, chondrocytes
present in developing articular cartilage, tracheal rings,
nasal septum, and intervertebral discs do not enter the
maturation and endochondral processes and these carti-
laginous structures thus persist throughout life as perma-
nent cartilage (Pacifici, 1995). Chondrocytes undergoing
the endochondral process are responsible for formation
and growth of most bones, including longitudinal bones,
vertebrae, and ribs, whereas chondrocytes that organize
permanent cartilage tissues exert a continuous function,
including providing resilience to joints and tracheal rings
and allowing normal biomechanical movements. There-
fore, tight regulation of cartilage phenotype specification
is very important for assembly and function of skeletal
structures. However, it has not been fully understood how
chondrocytes enter the endochondral process or acquire
and maintain the permanent phenotype.
Core binding factor 
 
a
 
1 (Cbfa1)
 
1
 
/Runx2 (runt-related
gene 2) is an essential transcription factor in osteoblast
differentiation and bone formation (Ducy et al., 1997;
 
Komori et al., 1997; Otto et al., 1997). 
 
Cbfa1
 
-deficient
mice display a complete lack of both intramembranous
and endochondral ossification and show an absence of
osteoblast differentiation, as well as retardation of
chondrocyte differentiation (Komori et al., 1997; Otto
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et al., 1997; Inada et al., 1999; Kim et al., 1999). Further,
Cbfa1 has the ability to stimulate chondrocyte maturation
in vitro (Enomoto et al., 2000). Thus, a main function of
Cbfa1 in chondrocytes in vivo appears to be promotion of
their maturation and endochondral ossification. However,
it may be that chondrocyte differentiation leading to endo-
chondral ossification is largely controlled by the surround-
ing cells, osteoblastic and hematopoietic cells, and that a
lack of 
 
Cbfa1
 
 in chondrocytes may not be a major reason
for suppression of chondrocyte maturation. Thus, the
mechanism of inhibition of endochondral ossification seen
in 
 
Cbfa1
 
-deficient mice remains to be solved.
To examine the roles of Cbfa1 in endochondral ossification
and cartilage phenotype specification, we generated trans-
genic mice, which overexpress Cbfa1 or a dominant negative
(DN)-Cbfa1 form in chondrocytes under the control of pro-
moter/enhancer elements of the 
 
a
 
1 type II collagen gene
(
 
Col2a1
 
). 
 
Cbfa1
 
 and DN-
 
Cbfa1
 
 transgenic mice showed, re-
spectively, accelerated and decelerated chondrocyte matura-
tion and endochondral ossification. Further, permanent carti-
lage lost its permanent phenotype and entered into the
endochondral process in 
 
Cbfa1
 
 transgenic mice, whereas
most of the chondrocytes in DN-
 
Cbfa1
 
 transgenic mice re-
tained the phenotype of permanent cartilage. These data
demonstrate that Cbfa1 plays an important role not only in
chondrocyte maturation in the process of endochondral ossi-
fication, but also in the specification of cartilage phenotype.
 
Materials and Methods
 
Generation of Transgenic Mice
 
DNA fragments covering the entire coding region of the mouse type I and
II Cbfa1 isoforms (Harada et al., 1999) were cloned into the NotI site of a
 
Col2a1
 
-based expression vector, which contains promoter and enhancer
of mouse 
 
Col2a1
 
 gene (sequence data available from EMBL/GenBank/
DDBJ under accession number M65161, 1940–2971 nt, and 4930–5571 nt,
respectively) in pNASS
 
b
 
 (CLONTECH Laboratories, Inc.). The fragment
of the 
 
Col2a1
 
 first intron contains tissue-specific elements (Zhou et al.,
1995; Krebsbach et al., 1996). Two forms of the DN-
 
Cbfa1
 
, which contain
the runt domain only (395-bp NcoI-HindIII fragment) and the runt do-
main with NH
 
2
 
-terminal domain of type I 
 
Cbfa1
 
 (673-bp BamHI-HindIII
fragment; BamHI is a site in the cloning vector), were cloned into the NotI
site of the 
 
Col2a1
 
-based expression vector. The construct inserts, includ-
ing 
 
b
 
-galactosidase with 
 
Col2a1
 
 promoter/enhancer, were injected into
the pronuclei of fertilized eggs from F1 hybrid mice (C57BL/6 
 
3
 
 C3H).
Transgenic embryos were identified by Southern blot. Transgene expres-
sion was assessed by Northern blot as described previously (Komori et al.,
1997), using RNA from the head or trunk of embryonic day 12.5–18.5
(E12.5–18.5) embryos and a 
 
32
 
P-labeled NcoI-HindIII fragment of 
 
Cbfa1
 
cDNA as a probe. Filters were rehybridized with a 
 
32
 
P-labeled 0.85-kb frag-
ment of mouse glyceraldehyde-3-phosphate-dehydrogenase (GAPDH).
 
DNA Transfections and Luciferase Assays
 
Type I 
 
Cbfa1
 
, type II 
 
Cbfa1
 
, and DN-
 
Cbfa1
 
 (673-bp BamHI-HindIII frag-
ment) were subcloned into the pSG5 vector (Stratagene) as described
(Harada et al., 1999) and designated pSG5-type I 
 
Cbfa1
 
, pSG5-type II
 
Cbfa1
 
, and pSG5–DN-
 
Cbfa1
 
, respectively. Insertless pSG5 vector (pSG5)
was used as a control expression vector. A pGL3 promoter vector
(Promega), containing six repeats of the consensus Cbfa1 binding sites,
was used as an experimental reporter vector (p6XOSE2-Luc) (Harada et
al., 1999). A pRL-SV40 vector (Promega) was used as a control reporter
vector. Subconfluent cultures of chick sterna chondrocytes in a 6-well
plate were transfected with 0.5 
 
m
 
g of p6XOSE2-Luc, 0.2 
 
m
 
g of pRL-SV40,
and 3.3 
 
m
 
g of a mixture of pSG5 expression vectors with LipofectAMINE
2000 reagent (GIBCO BRL). After 48 h, cells were harvested and firefly
luciferase activities generated by experimental reporter, and Renilla lu-
ciferase activity generated by control reporter, were simultaneously mea-
sured by Dual-Luciferase reporter assay system (Promega). The value of
 
reporter gene activity was calculated by dividing firefly luciferase activity
by Renilla luciferase activity and the result was expressed as relative lu-
ciferase activity. Transfection and reporter gene assay were carried out ac-
cording to the manufacturer’s protocol.
 
Skeletal, Histological, and
Immunohistochemical Examinations
 
For staining and visualization of the whole skeleton, cleared skeletons of
E15.5–18.5 embryos were stained with Alizarin red–S and Alcian blue as
described (Komori et al., 1997). For light microscopy, tissues from E12.5–
18.5 embryos were fixed in 4% paraformaldehyde/0.1 M phosphate buffer.
Sections (7 
 
m
 
m in thickness) were stained with hematoxylin and eosin
(H-E). Selected samples were stained using von Kossa’s method to iden-
tify mineralized tissues (Komori et al., 1997). For immunohistochemical
analysis, the sections were pretreated with 0.2% pepsin in 0.02 N HCl for 15
min at 37
 
8
 
C and then incubated with rabbit anti–mouse tenascin antibody
(Kalembey et al., 1997) for 16 h at 4
 
8
 
C. Localization of the first antibody
was visualized by incubation with biotinylated anti–rabbit IgG (Vector
Laboratories) for 30 min at room temperature and then with Cy3-conju-
gated Streptavidin (Jackson ImmunoResearch Laboratories) for 30 min at
room temperature.
 
Detection of 
 
b
 
-Galactosidase Activity
 
For the detection of 
 
b
 
-galactosidase activity, embryos were fixed with 4%
paraformaldehyde in PBS (pH 7.4) at 4
 
8
 
C for 20 min. The samples were
then rinsed in PBS, subsequently transferred into X-gal reaction mixture
(1 mg/ml 4-chloro-5-bromo-3-indolyl-
 
b
 
, 4 mM K
 
4
 
Fe[CN]
 
6
 
3H
 
2
 
O, 4 mM
K
 
3
 
Fe[CN]
 
6
 
, 2 mM MgCl
 
2
 
 in PBS), and incubated at 30
 
8
 
C overnight.
Stained embryos were embedded in paraffin and used to generate 7-
 
m
 
m
sections, which were counterstained with eosin.
 
In Situ Hybridization
 
Digoxigenin 11 UTP-labeled single-stranded RNA probes were prepared
using a DIG RNA labeling kit (Roche Biochemica) according to the man-
ufacturer’s instructions. A 0.4-kb fragment of mouse 
 
a
 
1(II) collagen
cDNA (Komori et al., 1997), a 0.65-kb fragment of mouse 
 
a
 
1(X) collagen
cDNA (Inada et al., 1999), a 0.8-kb fragment of mouse parathyroid hor-
mone/parathyroid hormone–related peptide (PTH/PTHrP) receptor
cDNA (Inada et al., 1999), a 0.6-kb fragment of mouse Indian hedgehog
(
 
Ihh
 
) cDNA (Inada et al., 1999), and a 0.27-kb fragment of mouse growth
and differentiation factor (
 
GDF
 
)
 
-5
 
 cDNA were used to generate anti-
sense and sense probes. Hybridization was carried out as described (Inada
et al., 1999).
 
Cell Cultures and Virus Infection
 
Chick sterna chondrocytes were isolated from 17-d-old embryo (line M)
sternum, infected with the RCAS retroviral vector encoding type I 
 
Cbfa1
 
,
or the runt domain with NH
 
2
 
-terminal domain of type I 
 
Cbfa1
 
, and cul-
tured in high-glucose DME containing 10% FBS and 10 
 
m
 
g/ml of ascorbic
acid as described previously (Enomoto-Iwamoto et al., 1998; Enomoto et
 
Table I. Production Frequency of Transgenic Mice
 
Transgene
construct Stage of killing
Embryos
obtained
Transgenic
mice
Transgenic mice
with phenotype*
 
Embryonic day
 
Cbfa1
 
‡
 
12.5 230 (111) 37 (15) 13 (7)
13.5 133 (86) 24 (19) 12 (8)
14.5 170 (122) 35 (25) 24 (14)
15.5 250 (72) 36 (15) 18 (10)
16.5 99 (57) 8 (6) 5 (4)
18.5 231 (111) 46 (14) 20 (6)
DN-Cbfa1 12.5 38 8 5
14.5 23 5 3
15.5 9 3 2
16.5 11 2 1
18.5 121 21 10
 
*The numbers for E12.5–14.5 are obtained by Northern blot analysis.
 
‡
 
The numbers of type I and II 
 
Cbfa1
 
 transgenic mice are combined and the numbers
of type II 
 
Cbfa1
 
 transgenic mice are shown in parentheses. 
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al., 2000). On day 5, the cultures were replated in 24-well plates or 60-mm
dishes at the density of 3 
 
3
 
 10
 
5 
 
per well and 10
 
6
 
 per dish, respectively. Af-
ter 5 d the cultures in 60-mm dishes were subjected to immunoblot and
Northern blot analyses (Inada et al., 1999). The cultures in 24-well plates
were maintained for 8 d, then treated with 3 mM 
 
b
 
-glycerophosphate for
the additional 2 d and fixed for histochemical examination (Enomoto et
al., 2000). The first antibody used was a polyclonal rabbit antibody against
the NH
 
2
 
-terminal domain of type I Cbfa1, provided by Y. Ito (Kyoto Uni-
versity, Kyoto, Japan). Chick type II collagen, type X collagen, and tenascin
cDNAs used for probes were described previously (Pacifici et al., 1993).
 
Results
 
Skeletal Abnormalities of Cbfa1 or DN-Cbfa1 
Transgenic Mice
 
To generate mice that overexpressed Cbfa1, we used two
Cbfa1 isoforms with different NH
 
2
 
 termini (Fig. 1, Table
I). The first one, translated from exon 2, was originally
named Pebp2
 
a
 
A (hereafter termed type I Cbfa1; Ogawa
et al., 1993); the other, translated from exon 1, was called
til-1 isoform (hereafter termed type II Cbfa1; Stewart et
al., 1997). Mice overexpressing type I or II Cbfa1 died at
birth from respiratory failure. At E18.5, they displayed se-
vere dwarfism, with shortened limbs, domed skull, and a
protruding tongue with a shortened snout and mandible
(Fig. 1 C). Most skeletal elements, including the chondro-
 
cranium, ribs, and vertebrae, showed massive mineraliza-
tion with severely reduced cartilaginous portions, and the
thoracic cage was narrow and bell-shaped (Fig. 2, B, C, F,
G, J, and K). As to be expected, age-matched wild-type
mice displayed cartilaginous tissues in the joints, ventral
portion of ribs, and vertebral bodies (Fig. 2, A, E, I, and
M). In addition, most skeletal elements in the transgenic
mice were fused, except manus and pedis (Fig. 2, B and
C). Shoulder, elbow, hip, and knee joints were absent, and
the vertebral bodies and arches were fused (Fig. 2, J, K, N,
and O). The overall phenotypes of type I and II 
 
Cbfa1
 
transgenic mice were generally similar, although type II
 
Cbfa1
 
 transgenic mice seemed to develop these severe ab-
normalities slightly earlier than type I 
 
Cbaf1
 
 transgenic
mice (Fig. 3).
To inactivate Cbfa1 function in chondrocytes, we gener-
ated additional lines of transgenic mice that express DN
forms of Cbfa1 in chondrocytes under the control of the
same 
 
Col2a1
 
 promoter/enhancer elements used above
(Fig. 1, Table I). We constructed cDNAs encoding the
runt domain only or runt domain with NH
 
2
 
-terminal do-
main of type I 
 
Cbfa1
 
. Both truncated forms of Cbfa1 had
strong DN activity and were able to block the function of
both type I and II Cbfa1 in reporter assays using osteo-
blast-specific elements and/or osteocalcin promoter frag-
Figure 1. Generation of trans-
genic mice. (A) Diagrams of
the DNA constructs used to
generate Col2a1-type I Cbfa1,
Col2a1-type II Cbfa1, and
Col2a1–DN-Cbfa1 transgenic
mice. DNA fragments cover-
ing the entire coding region of
the mouse type I or II Cbfa1
isoforms were inserted into a
Col2a1-based expression vec-
tor, which contains promoter
and enhancer of mouse
Col2a1 gene. DNA fragments
encoding the runt domain
only or runt domain with
NH2-terminal domain of type
I Cbfa1 were also inserted
into the Col2a1-based expres-
sion vector to generate DN
forms of Cbfa1. Type I, type I
Cbfa1; Type II, type II Cbfa1;
DN, DN Cbfa1; Pr, Col2a1
promoter; En, Col2a1 en-
hancer; N, NotI; H, HindIII;
E, EcoRI; B, BamHI. (B)
Northern blot hybridized
with  Cbfa1 probe. RNA was
extracted from the head or
trunk of E12.5–18.5 embryos,
and 20 mg of total RNA was
loaded per lane. Representa-
tive data using RNA from heads of E12.5 embryos are shown. Lanes of wild-type (left), type I Cbfa1, and type II Cbfa1 transgenic mice
are on one filter and lanes of wild-type (right, W) and DN-Cbfa1 transgenic mice (T) are on the other filter. Arrows indicate the bands
of endogenous Cbfa1 and transgenes. Hybridization with the GAPDH probe was used as internal control for the loading of equal
amounts of RNA. (C) Gross appearance of wild-type, type I Cbfa1, type II Cbfa1, and DN-Cbfa1 transgenic mice at E18.5. Both type I
and II Cbfa1 transgenic mice exhibit dwarfism with domed skull, short snout and mandible, protruding tongue, and short limbs and tail.
DN-Cbfa1 transgenic mice exhibit dwarfism with short limbs. In DN-Cbfa1 transgenic mice, all of the presented data in this paper are
from mice that contain the runt domain with NH2-terminal domain of type I Cbfa1 except skeletal examinations, in which a mouse with
runt domain only is presented. Bar, 2 mm.The Journal of Cell Biology, Volume 153, 2001 90
ments (Fig. 4; Ducy et al., 1999). In both Cbfa1 and DN-
Cbfa1 transgenic mice, we did not observe apparent posi-
tive or negative regulation of endogenous Cbfa1 expres-
sion by the exogenous Cbfa1 and DN-Cbfa1 (Fig. 1 B).
Transgenic mice overexpressing either form of DN-
Cbfa1 also died soon after birth from respiratory failure
and displayed dwarfism with shortened limbs, just like
Cbfa1-deficient mice (Fig. 1 C) (Komori et al., 1997; Otto
et al., 1997). Staining of both types of DN-Cbfa1 trans-
genic mice at E18.5 with Alizarin red and Alcian blue re-
vealed severely delayed calcification (Fig. 2, D, H, L, and
P). Most skeletal elements, including ribs, occipital bone,
base of skull, and vertebral bodies, were still uncalcified
cartilaginous tissues, although a limited part of vertebral
arches and diaphyses of limb long bones were calcified. As
expected, most of the skull and clavicles, which are formed
by intramembranous ossification, were clearly mineralized
in the DN-Cbfa1 transgenic mice, in contrast to the ab-
sence of calcification in the skulls of Cbfa1-deficient mice
(Komori et al., 1997; Otto et al., 1997).
Overexpression of Cbfa1 Induced Precocious or 
Abnormal Endochondral Ossification
Developmental changes in cartilaginous skeletal elements
were examined histologically. In E18.5 wild-type mice, na-
sal septum cartilage consisted of small homogenous chon-
drocytes (Fig. 5 A), which is typical of permanent carti-
lage, whereas that of Cbfa1 transgenic mice was mostly
composed of hypertrophic chondrocytes and about half of
it had already been replaced by bone marrow and osteoid
Figure 2. Examination of skeletal system. Skele-
tal examination of wild-type mice (A, E, I, and M)
and type I Cbfa1 (B, F, J, and N), type II Cbfa1
(C, G, K, and O), and DN-Cbfa1 (D, H, L, and P)
transgenic mice at E18.5. Calcified tissues are
stained red with Alizarin red and the cartilage is
stained blue with Alcian blue. Representative
skeletons are shown. (A–D) Whole skeletons. In
wild-type mice, cartilaginous tissues are observed
in occipital bone, joints, the ventral portion of
ribs, and vertebral bodies (A). In both type I and
II Cbfa1 transgenic mice, most of the skeleton,
including occipital bone, most of the ribs, and all
of the vertebrae, is calcified (B and C). In DN-
Cbfa1 transgenic mice, calcification is limited in
flat bones of the head, mandible, clavicle, and
long bones (D). (E–H) Thoracic cages. In wild-
type mice, the ventral portion of all ribs is carti-
laginous and sternum is segmentally calcified
(E). In both type I and II Cbfa1 transgenic mice,
the thoracic cage is small and bell-shaped, and
the major portion of the ribs and sternum are
calcified (F and G). In DN-Cbfa1 transgenic
mice, the major portion of the ribs and the entire
region of the sternum are cartilaginous (H). (I–L)
Vertebral skeletons. In wild-type mice, centers of
vertebral bodies and most vertebral arches are
calcified (I). In both type I and II Cbfa1 trans-
genic mice, all of the vertebral bodies and arches
are united and calcified (J and K). In DN-Cbfa1
transgenic mice, all of the vertebral bodies and
arches are cartilaginous (L). (M–P) Forelimb
skeletons. In wild-type mice, calcification is lim-
ited in diaphyses of long bones and the center of
the scapula (M). In both type I and II Cbfa1
transgenic mice, the humerus is short and the hu-
merus, radius, and ulna are thick and united (N
and O). Shoulder joints and some carpal bones
are also fused (N and O). Most of the elbow joint
region is calcified and the calcified region is
wider than that in wild-type mice in all long
bones and scapula (N and O). In DN-Cbfa1
transgenic mice, calcification is limited around
diaphyses of the humerus, radius, and ulna (P).
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tissues (Fig. 5 B). In wild-type mice at E18.5, the vertebral
cartilage primordia just started to develop and consisted of
homogenous small chondrocytes sandwiched between
smaller mesenchymal cells destined to become interverte-
bral discs (Fig. 5 C). In Cbfa1 transgenic mice, vertebral
cartilage had largely been replaced by bone, and chondro-
cyte maturation and bone formation were also observed in
the presumed intervertebral regions (Fig. 5 D). In wild-
type mice at E18.5, thyroid, cricoid, and tracheal carti-
lages, all of which have the permanent phenotype, con-
sisted of small homogeneous chondrocytes (Fig. 5, E and
G), whereas those of Cbfa1 transgenic mice consisted of
mixed populations of hypertrophic and small chondro-
cytes and some regions that were replaced by bone (Fig. 5,
F and H). Further, tracheal rings were fused in Cbfa1
transgenic mice (Fig. 5 H). These data indicate that carti-
lage tissues that normally develop to permanent cartilage
proceeded to endochondral process in Cbfa1 transgenic
mice. In the developing mandible, membranous ossifica-
tion proceeds at some distance from Meckel’s cartilage,
the distal portion of Meckel’s cartilage is replaced with fi-
brous tissues, and the caudal part gives rise to ossicles,
such as malleus and incus, through endochondral ossifica-
tion (Chung et al., 1995). However, the distal portion of
Meckel’s cartilage in Cbfa1 transgenic mice displayed en-
dochondral ossification, whereas Meckel’s cartilage in
wild-type mice remained cartilaginous (Fig. 5, I–L). All of
these findings show that chondrocyte maturation had been
greatly enhanced in Cbfa1 transgenic mice, leading to ab-
normal behavior and development of most, if not all, carti-
laginous structures.
To establish more closely the differentiation state of
chondrocytes in the transgenic mice, we focused on limb
development. The Col2a1 promoter and enhancer frag-
ments that we used were able to mimic the temporal and
spatial expression of endogenous type II collagen, which is
expressed in chondroprogenitor cells as well as chondro-
cytes, but very weakly in hypertrophic chondrocytes, as re-
vealed by reporter activity (Fig. 6, A and B; Ng et al., 1993;
Zhou et al., 1995). At E12.5, when cartilage primordia be-
gin to form in the forelimbs, we observed no significant
differences in the overall size of the mesenchymal conden-
sations in wild-type and Cbfa1 transgenic mice, but the pri-
mordia of humerus and radius and those of humerus and
ulna appeared to have already fused in Cbfa1 transgenic
mice (Fig. 6, C and D). Thus, exogenous Cbfa1 expression
in chondroprogenitor cells did not seem to affect their dif-
ferentiation into chondrocytes (Fig. 6 D). In E15.5 wild-
type mice, humerus, radius, and ulna were well developed;
the diaphyses of these elements were undergoing replace-
ment by bone, and cartilage tissue remained at the epiphy-
ses and metaphyses organized in growth plates (Fig. 6 E).
Figure 3. Whole skeletons at
E15.5. The skeletal system
was also examined at E15.5
to compare type I (B) and
type II Cbfa1 transgenic mice
(C). (A) Wild-type mice at
E15.5. Mineralization is ad-
vanced in both type I and II
Cbfa1 transgenic mice in most
skeletal components, includ-
ing occipital bone, chondro-
cranium, ribs, vertebrae,
and long bones, but the
mineralization in type II
Cbfa1 transgenic mice is more
than that in type I Cbfa1 trans-
genic mice. The thoracic cage in type II Cbfa1 transgenic mice is smaller than that in type I Cbfa1 transgenic mice. Although fusion in joints
and vertebrae is observed in both type I and II Cbfa1 transgenic mice, it is more advanced in type II Cbfa1 transgenic mice. Representative
skeletons are shown. Bar, 1 mm.
Figure 4. DN effect of the truncated form of
Cbfa1, which contains the runt domain with NH2-
terminal domain of type I Cbfa1. 0.5 mg of Cbfa1
target gene reporter plasmid (p6XOSE2-Luc),
0.2 mg of control reference reporter plasmid
(pRL-SV40), and the indicated amounts of expres-
sion vectors were cotransfected into chick sterna
chondrocytes. Relative luciferase activity was calcu-
lated as described in Materials and Methods. Values
are means of four wells. Similar results were ob-
tained in two independent experiments.The Journal of Cell Biology, Volume 153, 2001 92
Figure 5. Endochondral ossification in cartilaginous tissues. (A and B) Frontal sections of the nasal septum from wild-type (A) and
Cbfa1 transgenic (B) mice at E18.5. In Cbfa1 transgenic mice, most chondrocytes are hypertrophic and half of the nasal septum is
replaced by bone (B). (C and D) Sagittal sections of the vertebral column from wild-type (C) and Cbfa1 transgenic (D) mice at
E18.5. Most of vertebral bodies are replaced by bone, and chondrocytes in intervertebral regions are hypertrophic and partly replaced
by bone in Cbfa1 transgenic mice (D). (E–H) Sagittal sections of the thyroid (Th), cricoid (C), and tracheal (Tr) cartilages from wild-
type (E and G) and Cbfa1 transgenic (F and H) mice at E18.5. In Cbfa1 transgenic mice, tracheal rings are fused, large areas in thyroid,
cricoid, and tracheal cartilages are occupied by hypertrophic chondrocytes, and some regions are replaced by bone (F and H). (G and
H) Higher magnifications of boxed regions in E and F, respectively. Arrowheads in F show the regions that are replaced by bone. (I–L)
Sections of the Meckel’s cartilage from wild-type (I and K) and Cbfa1 transgenic (J and L) mice at E18.5. In wild-type mice, Meckel’s
cartilage is intact, but most of it is replaced by bone in Cbfa1 transgenic mice. (K and L) Higher magnifications of boxed regions in I and
J, respectively. All sections were stained with H-E. Bars, 100 mm.Ueta et al. Cbfa1 and DN-Cbfa1 Transgenic Mice in Chondrocytes 93
Figure 6. Process of endochondral ossification in limbs. The forelimb (A) and hind limb (B) from b-galactosidase transgenic mice and the
forelimbs from wild-type (C, E, H, K, N, and Q), Cbfa1 transgenic (D, F, I, L, O, and R), and DN-Cbfal transgenic mice (G, J, M, P, and S)
were examined histologically. (A and B) b-Galactosidase staining in E11.5 (A) and E16.5 (B) transgenic mice expressing b-galactosidase
by Col2a1 promoter/enhancer. Staining is observed in chondroprogenitor cells in precartilaginous condensation (A). Staining is observed
in chondrocytes but very weakly in hypertrophic chondrocytes and the staining is absent in osteoblasts (B). (C and D) H-E staining at
E12.5. Humerus, radius, and ulna are uninterrupted in Cbfa1 transgenic mice (D). (E–J) H-E staining at E15.5. In Cbfa1 transgenic mice,
humerus, radius, and ulna remain fused and the growth plate is disorganized and mainly composed of hypertrophic chondrocytes in the
fused region (F and I). In DN-Cbfa1 transgenic mice, ulna remains cartilaginous and is composed of small immature chondrocytes and no
vascular invasion is observed (G and J). (H–J) Higher magnifications of boxed regions in E–G. (K–P) In situ hybridization using type II
collagen (K–M) and type X collagen (N–P) antisense probes at E15.5. In Cbfa1 transgenic mice, type II collagen expression is restricted in
epiphyses and a small part of the fused region (L), but type X collagen is widely expressed (O). In contrast, in DN-Cbfa1 transgenic mice,
type II collagen expression is observed in a whole part of humerus, radius, and ulna (M), and no type X collagen expression is detected (P).
(Q–S) von Kossa and H-E double staining at E18.5. Bones of Cbfa1 transgenic mice are heavily mineralized (R), whereas mineralization in
DN-Cbfa1 transgenic mice is restricted in bone collars and calcified cartilage in diaphysis of ulna (S). Bars: (A–P) 100 mm; (Q–S) 500 mm.The Journal of Cell Biology, Volume 153, 2001 94
Figure 7. Chondrocyte maturation in DN-Cbfa1 transgenic mice. Maturational stage of chondrocytes in DN-Cbfa1 transgenic mice at E18.5
(A–C, E, G, and H) was examined with wild-type mice at E15.5 as positive control (D and F) by in situ hybridization using a type II collagen
probe (B), PTH/PTHrPR probe (C and D), Ihh probe (E and F), and type X collagen probe (G and H). (A) H-E staining. In DN-Cbfa1 trans-
genic mice, a series of sections from the tibia is used in A–C, E, and G and a series of sections from the radius and ulna is used in H and Fig. 6
S. In wild-type mice, a series of sections from the tibia and fibula are used (D and F). In DN-Cbfa1 transgenic mice, most chondrocytes expressUeta et al. Cbfa1 and DN-Cbfa1 Transgenic Mice in Chondrocytes 95
In these growth plates, type II collagen expression was
gradually decreased toward the hypertrophic zone (Fig. 6
K) and type X collagen was conversely upregulated (Fig. 6
N). In Cbfa1 transgenic mice, these bones were fused and
the growth plate was disorganized, as revealed by both the
histological appearance and gene expression profile: carti-
lage tissues at the fused joint regions consisted of enlarged
chondrocytes (Fig. 6, F and I) expressing type X collagen
(Fig. 6 O) and a small number of type II collagen–positive
cells (Fig. 6 L). Thus, overexpression of Cbfa1 induced
precocious and spatially abnormal expression of the hy-
pertrophic phenotype. In E18.5 Cbfa1 transgenic mice, the
fused forelimb skeletal elements displayed gross mineral-
ization (Fig. 6 R), leading to the conclusion that activation
of Cbfa1 signaling in immature chondrocytes promoted
hypertrophy and precocious endochondral ossification.
DN-Cbfa1 Expression Severely Inhibited Chondrocyte 
Maturation and Endochondral Ossification
In DN-Cbfa1 transgenic mice at E15.5, humerus, radius,
and ulna remained entirely cartilaginous and were com-
posed of immature chondrocytes expressing type II col-
lagen, but not type X collagen (Fig. 6, M and P). The
formation of bone collars, which are formed by intramem-
branous ossification, was not observed (Fig. 6, G and J)
and it was confirmed by von Kossa’s staining (data not
shown). In E18.5 DN-Cbfa1 transgenic mice, bone collars
of humerus, radius, and ulna appeared, but vascular in-
vasion into the cartilage was rarely observed, indicating
severe delay or blockage of endochondral ossification
(Fig. 6 S). The inhibition of endochondral ossification in
DN-Cbfa1 transgenic mice seemed mainly to originate
from retarded maturation of chondrocytes, as indicated by
the expression of type II collagen and lack of PTH/PTHrP
receptor (PTHrPR), Ihh, and type X collagen in most of
the diaphyses (Fig. 7). Transgenic mice overexpressing ei-
ther form of DN-Cbfa1 showed similar phenotypes in all
histological analyses (data not shown).
The phenotype induced by DN-Cbfa1 in chondrocytes
was also studied in vitro. Chondrocytes were isolated from
sterna cartilage of chick embryo and forced to express
DN-Cbfa1 (Fig. 8 A). The cells retained their small size
(Fig. 8 B, DN-Cbfa1), and failed to induce alkaline phos-
phatase activity (Fig. 8 C), matrix calcification (Fig. 8 C,
Figure 8. Expression of
Cbfa1 and DN-Cbfa1 in cul-
tured chondrocytes. Chick
sterna chondrocytes were in-
fected with avian retrovirus
RCAS (A) encoding type I
Cbfa1 (Cbfa1) or the runt
domain with NH2-terminal
domain of type I Cbfa1 (DN-
Cbfa1). Control cultures
(Control) were infected with
RCAS (A) virus encoding
vector alone. (A) Immuno-
blot of the introduced gene
products. (B) Photographs of
cultures 5 d after virus infec-
tion. (C) Histochemical anal-
ysis of alkaline phosphatase
activity (APase) and matrix
calcification (Alizarin-red).
(D) Northern blot of type II
collagen (Type II), type X
collagen (Type X), and tenas-
cin (TN). Expression of DN-
Cbfa1 retained the small cell
size (B) and high levels of te-
nascin and type II collagen
expression (D), whereas it
inhibited the induction of al-
kaline phosphatase (C), ma-
trix calcification (C), and
type X collagen (D), indicat-
ing that DN-Cbfa1 disturbed
chondrocyte maturation and
maintained it in an early de-
velopmental state.
type II collagen (B) but not PTH/PTHrPR (C), Ihh (E), or type X collagen (G). PTH/PTHrPR (D) and Ihh (F) are strongly expressed in pre-
hypertrophic and early hypertrophic chondrocytes in wild-type mice. In DN-Cbfa1 transgenic mice, PTH/PTHrPR expression is restricted in
osteoblastic cells in bone collar (C). A few type X collagen–positive cells are seen close to hematopoietic cells that invaded to inside the bone
collar of radius and ulna in DN-Cbfa1 transgenic mice (H). Bar, 100 mm.The Journal of Cell Biology, Volume 153, 2001 96
Alizarin-red), and type X collagen expression (Fig. 8 D,
Type X), whereas Cbfa1 induced a larger cell size and
strongly stimulated expression of hypertrophic phenotype
markers as reported previously (Fig. 8, B–D; Enomoto et
al., 2000). The observations in Cbfa1 and DN-Cbfa1 trans-
genic mice, coupled with the in vitro results, clearly dem-
onstrate that Cbfa1 plays a pivotal role in chondrocyte
maturation in the process of endochondral ossification.
Activation of Cbfa1 Disturbed GDF-5 Expression 
and Inhibited Tenascin Expression in Joint-forming 
Regions, Whereas Inactivation of Cbfa1 Resulted 
in Broadly Retained Tenascin Expression in 
Cartilage Elements 
Fusion of skeletal elements seen in Cbfa1 transgenic
mice was accompanied with abnormal replacement of car-
tilage tissues by bone, suggesting that induction of endo-
chondral ossification by Cbfa1 is a reason for their malfor-
mation. However, fusion of cartilaginous components was
observed at much earlier times than when ossification be-
gan. To understand the mechanism of joint fusion seen in
Cbfa1 transgenic mice, we examined the expression of
GDF-5 and tenascin during limb development. GDF-5 is
implicated in joint specification through its expression in
prospective joints and its disruption in brachypodism
mouse mutation (Storm et al., 1994; Storm and Kingsley,
1996). GDF-5 expression was detected in shoulder but not
in knee and elbow, and its appearance in digital rays was
delayed in Cbfa1 transgenic mice (Fig. 9, B, D, F, and G)
compared with wild-type mice (Fig. 9, A, C, and E).
Therefore, Cbfa1 interrupted joint development in elbow
and knee at an early stage, probably by affecting factors
that determine future joint regions.
Tenascin is expressed in chondrocytes once cartilage tis-
sue appears, but becomes limited to the articular chondro-
cytes as cartilage development progresses (Pacifici, 1995).
In wild-type mice at E15.5, several layers of chondrocytes at
the edge of the epiphysis expressed tenascin, whereas chon-
drocytes in the presumptive joint region in Cbfa1 transgenic
mice did not, suggesting that the cells had lost permanent
phenotype (Fig. 10, A, B, D, and E). In the shoulder of
Cbfa1 transgenic mice, joint formation was observed at
E12.5, but the joint was fused at E15.5 (Figs. 9 F and 10 H),
Figure 9. GDF-5 expression
in developing limbs. (A–D)
Whole-mount in situ hybridiza-
tion of hind limbs from wild-
type (A and C) and Cbfa1
transgenic (B and D) mice us-
ing antisense GDF-5 probe. In
wild-type mice, GDF-5 expres-
sion was detected in knee and
metatarsophalangeal joints at
E12.5 (A). Additional stripes
of expression are seen in inter-
phalangeal joints and between the developing rows of tarsals at E13.5 (not shown)
and E14.5 (C), whereas no GDF-5 expression was detected in the knee (B and D)
and its expression in digital rays first appeared at E14.5 in Cbfa1 transgenic mice (D).
A and B, E12.5; C and D, E14.5. In addition, GDF-5 expression in metatarsopha-
langeal joints is weak and no expressions between the developing tarsals are seen in
Cbfa1 transgenic mice at E14.5 (D). (E–G) In situ hybridization of GDF-5 using sec-
tions from forelimbs of wild-type (E) and Cbfa1 transgenic (F and G) mice at E12.5.
GDF-5 expression is clearly localized to the joint regions of the shoulder and elbow in
wild-type mice (E). In Cbfa1 transgenic mice, GDF-5 expression is detected in the
shoulder (F), but not in the elbow (G) joints. S, scapula; H, humerus; R, radius; U,
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indicating that Cbfa1 inhibited chondrocytes from acquiring
the characteristics of articular cartilage. In contrast, many
chondrocytes in DN-Cbfa1 transgenic mice expressed te-
nascin (Fig. 10, C and F). Thus, most regions of developing
cartilaginous elements in DN-Cbfa1 transgenic mice ap-
peared to be at an early stage of cartilage development and
retained the expression of a marker for permanent carti-
lage. The same regulation of tenascin gene expression by
Cbfa1 was observed in vitro. Cbfa1 ceased tenascin expres-
sion, whereas dysfunction of Cbfa1 sustained it (Fig. 8 D).
Discussion
Our results show that overexpression of Cbfa1 in growth
plate chondrocytes accelerates maturation and endochon-
dral ossification, whereas misexpression in presumptive
permanent chondrocytes (such as articular chondrocytes)
alters the developmental fate of the cells, resulting in the
replacement of permanent cartilage by bone. Precocious
or abnormal bone formation mediated by the endochon-
dral ossification process is likely to be the cause of the
malformations seen in Cbfa1 transgenic mice, including
hypoplasia of the skull, shortening of long bones, fusion of
vertebrae, contraction of the thoracic cage, and joint fu-
sion. In contrast, interference with Cbfa1 function in carti-
lage suppresses chondrocyte maturation and matrix calci-
fication and also delays specification of cell phenotype to
articular cartilage, as determined by tenascin expression.
DN-Cbfa1 transgenic mice also displayed skeletal defor-
mities, mainly because of the loss or retardation of endo-
chondral ossification. Cbfa1 expression is at a low level in
chondrocytes at the beginning of cartilage development, is
barely detectable in permanent cartilage, and is upregu-
lated in hypertrophic chondrocytes in growth plate (Inada
et al., 1999; Kim et al., 1999; our unpublished data). There-
fore, it is likely that spatially and temporally regulated ex-
pression of Cbfa1 in chondrocytes is crucial for the control
of skeletal formation throughout the body.
Our data clearly demonstrate that Cbfa1 plays a crucial
role in chondrocyte maturation in the process of endo-
Figure 10. Tenascin expression in developing limbs. (A–F) Immunohistochemistry of elbow joint regions (A–C) and shoulder joint re-
gions (D–F) from wild-type (A and D), Cbfa1 transgenic (B and E), and DN-Cbfa1 transgenic (C and F) mice at E15.5 using antitenascin
antibody. Tenascin is strongly expressed along the edge of epiphysis and perichondrium and in bone of wild-type mice (A and D), but
not in presumptive joint regions of Cbfa1 transgenic mice (B and E). In DN-Cbfa1 transgenic mice, tenascin is expressed more abun-
dantly in the humerus, radius, and ulna (C and F). (G–I) H-E staining in the shoulder joint regions from wild-type (G), Cbfa1 transgenic
(H), and DN-Cbfa1 transgenic (I) mice at E15.5. R, radius; U, ulna; H, humerus; S, scapula. Bars: (A–F) 300 mm; (G–I) 50 mm.The Journal of Cell Biology, Volume 153, 2001 98
chondral ossification and suggest that the retardation of
chondrocyte maturation in Cbfa1-deficient mice was
mainly caused by a lack of Cbfa1 in chondrocytes, not a
lack of osteoblast differentiation or invasion of hemato-
poietic cells. However, the retardation of chondrocyte
maturation observed in DN-Cbfa1 transgenic mice was se-
verer than that seen in Cbfa1-deficient mice, although
bone collars in diaphyses were generated and blood ves-
sels invaded the bone collars in DN-Cbfa1 transgenic
mice. In Cbfa1-deficient mice, the entire skeleton con-
sisted of cartilage, most of which was composed of resting
or proliferating chondrocytes, which lack the expression of
PTH/PTHrPR, Ihh, and type X collagen (Inada et al.,
1999; Kim et al., 1999). However, chondrocyte maturation
was observed in the restricted skeleton, including tibia,
fibula, radius, and ulna. Calcification occurred in these ar-
eas, and PTH/PTHrPR, Ihh, and type X collagen expres-
sion was observed in their prehypertrophic and hyper-
trophic chondrocytes (Inada et al., 1999; Kim et al., 1999).
However, in DN-Cbfa1 transgenic mice hypertrophic
chondrocytes were rare throughout the skeleton. Even in
the tibia, fibula, radius, and ulna, only small numbers of
cells expressed PTH/PTHrPR, Ihh, or type X collagen. As
DN-Cbfa1 is expected to inhibit the expression of all runt
family genes including Cbfa2/Runx1 and Cbfa3/Runx3
(Sakakura et al., 1994), runt family genes other than Cbfa1
might also be involved in chondrocyte maturation.
Ihh was considered to regulate chondrocyte differentia-
tion via PTHrP and its receptor (Vortkamp et al., 1996;
Zau et al., 1997). Consequently, Ihh suppresses the differ-
entiation of prehypertrophic chondrocytes into hyper-
trophic chondrocytes. As chondrocyte maturation was ar-
rested before the prehypertrophic stage in DN-Cbfa1
transgenic mice, the maturational disturbance cannot be
explained by Ihh signaling. In DN-Cbfa1 transgenic mice,
delayed bone collar formation is probably due to low Ihh
expression in chondrocytes (Figs. 6, G and J, and 7 E),
whose level is less than the detection level of in situ hy-
bridization, because Ihh-deficient mice displayed a com-
plete lack of bone collar formation (St.-Jacques et al.,
1999). Our data also indicate that osteoblast differentia-
tion in the perichondrial region has no significant support-
ive effect on chondrocyte maturation at least in the ab-
sence of runt family factors in chondrocytes. Further
evidence is provided by the finding that chondrocytes be-
came hypertrophic in the absence of osteoblast differenti-
ation in the perichondrial region of Ihh-deficient mice (St.-
Jacques et al., 1999). However, vascular invasion seemed
to support chondrocyte maturation, because a few type X
collagen-positive cells appeared close to hematopoietic
cells that had invaded to the inside of the bone collar in
DN-Cbfa1 transgenic mice (Fig. 7 H).
Cbfa1 isoforms with different NH2 termini have been
shown to have different transcriptional activities in genes of
bone matrix proteins, including type I collagen and osteo-
calcin, in vitro (Tuji et al., 1998; Harada et al., 1999), al-
though the functional difference remains to be clarified in
vivo. We could not find functional differences between
Cbfa1 isoforms in chondrocyte maturation, and both iso-
forms strongly stimulated chondrocyte maturation. How-
ever, type II Cbfa1 seemed to exert stronger activity in stim-
ulating chondrocyte maturation than type I Cbfa1 (Fig. 3).
This was also observed during in vitro experiments using
chick primary chondrocytes (Enomoto et al., 2000). Differ-
ences in the function of the two Cbfa1 isoforms in chondro-
cytes need to be further investigated, especially in hyper-
trophic chondrocytes in which Cbfa1 and matrix protein
genes related to calcification are highly expressed. Cbfa1 in-
duced the differentiation of two lineage cells, osteoblasts
and chondrocytes (Komori, 2000). As the two Cbfa1 iso-
forms are expressed in chondrocytes as well as osteoblasts,
isoform-dependent induction of each lineage differentiation
is not valid. It has been shown that Ets1 works coopera-
tively with Cbfa1 in transactivation of the osteopontin gene
(Sato et al., 1998). Although transcription factors that spe-
cifically interact with Cbfa1 in chondrocytes have not been
identified, it is suggested that additional transcription fac-
tors required for cooperative work with Cbfa1 are different
in chondrocyte and osteoblast differentiation.
The mechanism of specification of permanent cartilage
is largely unknown. However, other investigators and we
have reported that chondrocytes in permanent cartilage
are able to express the terminal differentiation phenotype
in vitro (Iwamoto et al., 1989; Pacifici et al., 1991; Stephens
et al., 1992). In Cbfa1 transgenic mice, permanent carti-
lages such as articular cartilage, tracheal rings, nasal sep-
tum, and intervertebral disc underwent endochondral ossi-
fication. Taken together, it is likely that even permanent
cartilage or cartilage fated to be permanent has the poten-
tial to be transient cartilage that enters endochondral
pathway, and that lack of cell hypertrophy and matrix
mineralization in permanent cartilage is due to negative
regulation by microenvironmental cues and mechanisms,
which could downregulate Cbfa1  expression. Degenera-
tion of permanent cartilage is a feature of pathological
change in osteoarthritis of the articular joints and hyperos-
tosis of spine, such as ankylosis spondylitis or spondylosis
of the spine (Sandell, 1995). These diseases often dis-
played abnormal bone formation from cartilage, including
subchondral bone sclerosis or osteophyte, associated with
ectopic expression of several molecules such as type X col-
lagen (von der Mark et al., 1992), osteopontin (Pullig et
al., 2000), and matrix metalloproteinase 13 (MMP13)
(Shlopov et al., 1997), which are normally specific to hy-
pertrophic chondrocytes. Therefore, it has been proposed
that the ossifying events in these diseases might be related
to uncontrolled behavior of permanent chondrocytes and
abnormal expression of hypertrophic phenotype. Ectopic
ossification and ectopic expression of hypertrophic chon-
drocyte markers are characteristics of Cbfa1-transgenic
mice. Further, Cbfa1 is able to induce the expression of os-
teopontin and MMP13 (Ducy et al., 1997; Komori et al.,
1997; Shlopov et al., 1997; Sato et al., 1998; Harada et al.,
1999; Inada et al., 1999; Jimenez et al., 1999; Porte et
al., 1999). These findings suggest that Cbfa1 activation
might be involved in permanent cartilage disorders. The
mechanisms regulating Cbfa1 expression in chondrocytes
are not yet fully clear and such information would provide
important clues into cartilage development, including per-
manent cartilage organization, as well as the pathogenesis
of osteoarthritis and spinal disorder.
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